Table 2 CMR Examination Data
All patients (n = 208) | Primary prevention (n = 115) | Secondary prevention (n = 93) | p–value | |
|---|---|---|---|---|
Heart rate, bpm | 68 ± 14 | 70 ± 14 | 64 ± 13 | 0.002 |
Systolic BP, mmHg | 127 ± 20 | 124 ± 20 | 130 ± 21 | 0.010 |
Diastolic BP, mmHg | 73 ± 12 | 73 ± 12 | 74 ± 12 | 0.888 |
LVEDV, ml | 249 ± 106 | 283 ± 111 | 207 ± 83 | < 0.001 |
LVESV, ml | 170 ± 102 | 207 ± 104 | 125 ± 78 | < 0.001 |
LVEF, % | 36 ± 15 | 30 ± 13 | 44 ± 13 | < 0.001 |
RVEDV, ml | 128 ± 65 | 133 ± 71 | 121 ± 55 | 0.163 |
RVESV, ml | 62 ± 48 | 66 ± 53 | 57 ± 40 | 0.139 |
RVEF, % | 54 ± 11 | 54 ± 12 | 56 ± 10 | 0.186 |
LGE positive (n = 206), n(%) | 135 (66) | 73 (65) | 62 (67) | 0.756 |
LV, LGE positive, n(%) | 132 (64) | 73 (65) | 59 (63) | 0.863 |
LV-LGE pattern (n = 132) | 0.862 | |||
subendocardial, n(%) | 82 (62) | 47 (64) | 35 (59) | |
subepicardial, n(%) | 14 (11) | 7 (10) | 7 (12) | |
midwall striae, n(%) | 23 (17) | 13 (18) | 10 (17) | |
midwall patchy, n(%) | 13 (10) | 6 (8) | 7 (12) | |
LV-LGE, segments | 4.1 ± 2.7 | 4.2 ± 2.8 | 4.0 ± 2.5 | 0.647 |
LV-LGE, % transmurality | 73 ± 25 | 75 ± 24 | 70 ± 26 | 0.243 |
RV, LGE positive, n(%) | 9 (4) | 2 (2) | 7 (8) | 0.044 |
LV thrombus, n(%) | 9 (4) | 5 (4) | 4 (4) | 0.987 |